The role of metabolic biomarkers in drug toxicity studies

Toxicology Mechanisms and Methods

Volumn 18, Issue 4, 2008, Pages 301-311

  Schnackenberg, Laura K ^a   Beger, Richard D ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomarkers; Metabolic profiling; Metabolomics; Metabonomics; Toxicity

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ANALYTIC METHOD; DRUG TOXICITY; HUMAN; KIDNEY INJURY; MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLISM; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SCREENING; TISSUE;

ANIMALIA;

EID: 45949108082     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701623193     Document Type: Review

References (101)

1. Adamcova, M., Sterba, M., Simunek, T., Potacova, A., Popeloya, O., Mazurova, Y., and Gersi, V. 2005. Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Expert Opin. Drug Saf. 4:457-472.
2. Amacher, D. E. 1998. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul. Toxicol. Pharmacol. 27:119-130.
3. Anthony, M. L., Beddell, C. R., Lindon, J. C., and Nicholson, J. K. 1994. Studies on the comparative toxicity of S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2-dichlorovinyl)-L-homocysteine and 1,1,2-trichloro-3,3,3-trifluoro-1- propene in the Fischer 344 rat. Arch. Toxicol. 69:99-110.
4. Anthony, M. L., Rose, V. S., Nicholson, J. K., and Lindon, J. C. 1995. Classification of toxin-induced changes in 1 H NMR spectra of urine using an artificial neural network. J. Pharm. Biomed. Anal. 13:205-211.
5. Antti, H., Bollard, M. E., Ebbels, T. M., Keun, H., Lindon, J. C., Nicholson, J. K., and Holmes, E. 2002. Batch statistical processing of 1H NMR-derived urinary spectral data. J. Chemometr. 16:461-68.
6. Azmi, J., Griffin, J. L., Antti, H., Shore, R. F., Johansson, E., Nicholson, J. K., and Holmes, E. 2002. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data. Analyst 127:271-276.
7. Azmi, J., Griffin, J. L., Shore, R. F., Holmes, E., and Nicholson, J. K. 2005. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: A metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products. Xenobiotica 35:839-852.
8. Bailey, W. J., and Ulrich, R. 2004. Molecular profiling approaches for identifying novel biomarkers. Expert Opin. Drug Saf. 3:137-151.
9. Beckwith-Hall, B. M., Nicholson, J. K., Nicholls, A. W., Foxall, P. J., Lindon, J. C., Connor, S. C., Abdi, M., Connelly, J., and Holmes, E. 1998. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11:260-272.
10. Beger, R. D., Schnackenberg, L. K., Li, D., and Dragan, Y. 2006. Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics 2:125-134.
11. Bleecker, M. L. 2000. The role of quantitative neurological examination in clinical neurotoxicology. Neurol. Clin. 18:563-578.
12. Bollard, M. E., Stanley, E. G., Lindon, J. C., Nicholson, J. K., and Holmes, E. 2005. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18:143-162.
13. Bundy, J. G., Spurgeon, D. J., Svendsen, C., Hankard, P. K., Osborn, D., Lindon, J. C., and Nicholson, J. K. 2002. Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling. FEBS Lett 521:115-120.
14. Clayton, T. A., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J. P., Le Net, J. L., Walley, R. J., Everett, J. R., and Nicholson, J. K. 2006. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073-1077.
15. Coen, M., Lenz, E. M., Nicholson, J. K., Wilson, I. D., Pognan, F., and Lindon, J. C. 2003. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 16:295-303.
16. Constantinou, M. A., Papakonstantinou, E., Benakia, D., Spraul, M., Shulpis, K., Koupparis, M. A., and Mikros, E. 2004. Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach. Anal. Chim. Acta 511:303-312.
17. Crockford, D. J., Holmes, E., Lindon, J. C., Plumb, R. S., Zirah, S., Bruce, S. J., Rainville, P., Stumpf, C. L., and Nicholson, J. K. 2006. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: Application in metabonomic toxicology studies. Anal. Chem. 78:363-371.
18. Daizo, A., Egashira, Y., and Sanada, H. 2005. Suppressive effect of corn bran hemicellulose on liver injury induced by D-galactosamine in rats. Nutrition 21:1044-1051.
19. Dhami, M. S., Drangova, R., Farkas, R., Balaza, T., and Feuer, G. 1979. Decreased aminotransferase activity of serum and various tissues in the rat after cefazolin treatment. Clin. Chem. 25:1263-1266.
20. Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., and Seeff, L. B. 2000. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin. Chem. 46:2050-2068.
21. Dumas, M. E., Barton, R. H., Tove, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., and Nicholson, J. K. 2006b. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA 103:12511-12516.
22. Dumas, M. E., Maibaum, E. C., Teague, C., Ueshima, H., Zhou, B., Lindon, J. C., Nicholson, J. K., Stamler, J., Elliott, P., Chang, Q., and Holmes, E. 2006a. Assessment of analytical reproducibility of 1 H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal. Chem. 78:2199-2208.
23. Dunn, W. B., and Ellis, D. I. 2005. Metabolomics: current analytical platforms and methodologies. Trends Anal. Chem. 24:285-294.
24. Ebbels, T., Keun, H., Beckonert, O., Antti, H., Bollard, M., Holmes, E., Lindon, J. C., and Nicholson, J. K. 2003. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta 490:109-122.
25. Ebbels, T. M., Keun, H. C., Beckonart, O. P., Bollard, M. E., Lindon, J. C., Holmes, E., and Nicholson, J. K. 2007. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res. 6:4407-4422.
26. Edmondson, R. D., Vondriska, T. M., Biederman, K. J., Zhang, J., Jones, R. C., Zheng, Y., Allen, D. L., Xiu, J. X., Cardwell, E. M., Pisano, M. R., and Ping, P. 2002. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol. Cell Proteomics 1:421-433.
27. Espandiari, P., Zhang, J., Rosenzweig, B., Sun, J., Schnackenberg, L. K., Vaidya, V. S., Herman, E. H., Miller, T. J., Knapton, A., Beger, R. D., Thompson, K., and Hanig, J. 2007. The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. Toxicol. Sci. 99:637-648.
28. Fiehn, O. 2002. Metabolomics-The link between genotypes and phenotypes. Plant Mol. Biol. 48:155-171.
29. Fiehn, O., Kristal, B., van Ommen, B., Sumner, L. W., Sansone, S. A., Taylor, C., Hardy, N., and Kaddurah-Daouk, R. 2006. Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. OMICS 10:158-163.
30. Fiehn, O., Robertson, D., Griffin, J., Van Der Werf, M., Nikolau, B., Morrison, N., Sumner, L. W., Goodacre, R., Hardy, N. W., Taylor, C., Fostel, J., Kristal, B., Kaddurah-Daouk, R., Mendes, P., van Ommen, B., Lindon, J. C., and Sansone, S. A. 2007. The metabolomics standards initiative (MSI). Metabolomics. 3:175-178.
31. Gambus, A., Jones, R. C., Sanchez-Diaz, A., Kanemaki, M., van Deursen, F., Edmondson, R. D., and Labib, K. 2006. GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks. Nat. Cell Biol. 8:358-366.
32. Garrod, S., Bollard, M. E., Nicholls, A. W., Connor, S. C., Connelly, J., Nicholson, J. K., and Holmes, E. 2005. Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem. Res. Toxicol. 18:115-122.
33. Gartland, K. P., Bonner, F. W., and Nicholson, J. K. 1989. Investigations into the biochemical effects of region-specific nephrotoxins. Mol. Pharmacol. 35:242-250.
34. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D., and Nicholson, J. K. 2000. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: Application to the C57BL10 J and Alpk:ApfCD mouse. FEBS Lett. 484:169-174.
35. Griffin, J. L. 2003. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol. 7:648-654.
36. Griffin, J. L., Pole, J. C., Nicholson, J. K., and Carmichael, P. L. 2003. Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1 H NMR spectroscopy. Biochim. Biophys. Acta 1619:151-158.
37. Gu, H., Chen, H., Pan, Z., Jackson, A. U., Talaty, N., Xi, B., Kissinger, C., Duda, C., Mann, D., Raftery, D., and Cooks, R. G. 2007. Monitoring diet effects via biofluids and their implications for metabolomics studies. Anal. Chem. 79:89-97.
38. Harrigan, G. G., and Yates, L. A. 2006. High-throughput screening, metabolomics and drug discovery. IDrugs 9:188-192.
39. Heijne, W. H., Lamers, R. J., van Bladeren, P. J., Groten, J. P., van Nesselrooij, J. H., and van Ommen, B. 2005. Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicol. Pathol. 33:425-433.
40. Holmes, E., Bonner, F. W., Sweatman, B. C., Lindon, J. C., Beddell, C. R., Rahr, E., and Nicholson, J. K. 1992. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. Mol. Pharmacol. 42:922-930.
41. Holmes, E., Tsang, T. M., and Tabrizi, S. J. 2006. The application of NMR-based metabonomics in neurological disorders. NeuroRx 3:358-372.
42. Kaplowitz, N. 2001. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 24:483-490.
43. Kaplowitz, N. 2005. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 4:489-499.
44. Keun, H. 2006. Metabonomic modeling of drug toxicity. Pharmacol. Ther. 109:92-106.
45. Keun, H. C., Antti, H., Bollard, M. E., Beckonert, O., Schlotterbeck, G., Senn, H., Niederhauser, U., Holmes, E., Lindon, J. C., and Nicholson, J. K. 2002. Analytical reproducibility in 1 H NMR-based metabonomic urinalysis. Chem. Res. Toxicol. 15:1380-1386.
46. Keun, H. C., Ebbels, T. M., Bollard, M. E., Beckonert, O., Antti, H., Holmes, E., Lindon, J. C., and Nicholson, J. K. 2004. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem. Res. Toxicol. 17:578-587.
47. Kucera, O., Cervinkova, Z., Lotkova, H., Krivakova, P., Rousar, T., Muzakova, V., Hezova, R., Kandar, R., and Rudolf, E. 2006. Protective effect of S-adenosylmethionine against galactosamine-induced injury of rat hepatocytes in primary culture. Physiol. Res. 55:551-560.
48. Lenz, E. M., Bright, J., Knight, R., Wilson, I. D., and Major, H. 2004a. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1 H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal. 35:599-608.
49. Lenz, E. M., Bright, J., Knight, R., Wilson, I. D., and Major, H. 2004b. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1 H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst 129:535-541.
50. Lenz, E. M., Bright, J., Knight, R., Westwood, F. R., Davies, D., Major, H., and Wilson, I. D. 2005. Metabonomics with 1 H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 10:173-187.
51. Lenz, E. M., Nicholson, J. K., Wilson, I. D., and Timbrell, J. A. 2000. A 1 H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: Evaluation of potential biomarkers. Biomarkers 5:424-435.
52. Lenz, E. M., and Wilson, I. D. 2007. Analytical strategies in metabonomics. J. Proteome Res. 6:443-458.
53. Lewis, J. H. 1984. Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin. Pharm. 3:128-138.
54. Lindon, J. C., Nicholson, J. K., and Everett, J. R. 1999. NMR spectroscopy of biofluids. In: Webb, G. A. (Ed.), Annual Review of NMR Spectroscopy, Academic Press, San Diego, pp. 2-88.
55. Lindon, J. C., Nicholson, J. K., Holmes, E., Antti, H., Bollard, M. E., Keun, H., Beckonert, O., Ebbels, T. M., Reily, M. D., Robertson, D., Stevens, G. J., Luke, P., Breau, A. P., Cantor, G. H., Bible, R. H., Niederhauser, U., Senn, H., Schlotterbeck, G., Sidelmann, U. G., Laursen, S. M., Tymiak, A., Car, B. D., Lehman-McKeeman, L., Colet, J. M., Loukaci, A., and Thomas, C. 2003. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187:137-146.
56. Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., and Nicholson, J. K. 2004. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9:1-31.
57. Lindon, J. C., Keun, H., Ebbels, T. M., Pearce, J. M., Holmes, E., and Nicholson, J. K. 2005a. The consortium for metabonomic toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6:691-699.
58. Lindon, J. C., Nicholson, J. K., Holmes, E., Keun, H. C., Craig, A., Pearce, J. T., Bruce, S. J., Hardy, N., Sansone, S. A., Antti, H., Jonsson, P., Daykin, C., Navarange, M., Beger, R. D., Verheij, E. R., Amberg, A., Baunsgaard, D., Cantor, G. H., Lehman-McKeeman, L., Earll, M., Wold, S., Johansson, E., Haseldon, J. N., Kramer, K., Thomas, C., Lindberg, J., Schuppe-Koistinen, I., Wilson, I. D., Reily, M. D., Robertson, D. G., Senn, H., Krotzky, A., Kochhar, S., Powell, J., Van Der Ouderaa, F., Plumb, R., Schaefer, H., and Spraul, M. 2005b. Summary recommendations for standardization and reporting of metabolic analyses. Nat. Biotechnol. 23:833-838.
59. Ma, X., Idle, J. R., Krausz, K. W., Tan, D. X., Ceraulo, L., and Gonzalez, F. J. 2006. Urinary metabolites and antioxidant products of exogenous melatonin in the mouse. J. Pineal Res. 40:343-349.
60. Moolenaar, S. H., Engelke, U. F., and Wevers, R. A. 2003. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 40:16-24.
61. Mortishire-Smith, R. J., Skiles, G. L., Lawrence, J. W., Spence, S., Nicholls, A. W., Johnson, B. A., and Nicholson, J. K. 2004. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol. 17:165-173.
62. Mosca, P., Bonazzi, P., Novelli, G., Jezequel, A. M., and Orlandi, F. 1985. In vivo and in vitro inhibition of hepatic microsomal drug metabolism by ketoconazole. Br. J. Exp. Pathol. 66:737-742.
63. Nava, M., Romero, F., Quiroz, Y., Parra, G., Bonet, L., and Rodriguez-Iturbe, B. 2000. Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats. Am. J. Physiol. Renal Physiol. 279:F910-F918.
64. Nicholson, J. K., Connelly, J., Lindon, J. C., and Holmes, E. 2002. Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1:153-162.
65. Nicholson, J. K., Holmes, E., and Wilson, I. D. 2005. Gut microbes, mammalian metabolism and personalized healthcare. Nat. Rev. Microbiol. 3:2-8.
66. Nicholson, J. K., Lindon, J. C., and Holmes, E. 1999. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181-1189.
67. Plumb, R. S., Granger, J. H., Stumpf, C. L., Johnson, K. A., Smith, B. W., Gaulitz, S., Wilson, I. D., and Castro-Perez, J. 2005. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130:844-849.
68. Plumb, R. S., Johnson, K. A., Rainville, P., Smith, B. W., Wilson, I. D., Castro Pervez, J. M., and Nicholson, J. K. 2006. UPLC/MS (E); a new approach for generating molecular fragment information for biomark structure elucidation. Rapid commun. Mass Spectrom 20:2234.
69. Plumb, R. S., Stumpf, C. L., Gorenstein, D. G., Castro-Perez, J. M., Dear, G. J., Anthony, M., Sweatman, B. C., Connor, S. C., and Haselden, J. N. 2002. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun. Mass Spectrom. 16:1991-1996.
70. Plumb, R. S., Stumpf, C. L., Granger, J. H., Castro-Perez, J., Haselden, J. N., and Dear, G. J. 2003. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom. 17:2632-2638.
71. Portilla, D., Li, S., Nagothu, K., Megyesi, J., Schnackenberg, L., Safirstein, R. L., and Beger, R. D. 2006. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int. 69:2194-2204.
72. Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M. C., Berden, J. A., Brindle, K. M., Kell, D. B., Rowland, J. J., Westerhoff, H. V., van Dam, K., and Oliver, S. G. 2001. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19:45-50.
73. Reo, N. V. 2002. NMR-based metabolomics. Drug Chem. Toxicol. 25:375-382.
74. Robertson, D., Reily, M. D., Sigler, R. E., Wells, D. F., Paterson, D. A., and Braden, T. K. 2000. Metabonomics: Evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol. Sci. 57:326-337.
75. Robertson, D. G., Reily, M. D., Albassam, M., and Dethloff, L. A. 2001. Metabonomic assessment of vasculitis in rats. Cardiovasc. Toxicol. 1:7-19.
76. Robertson, D. G. 2005. Metabonomics in toxicology: a review. Toxicol. Sci. 85:809-822.
77. Schnackenberg, L., Beger, R. D., and Dragan, Y. 2005. NMR-based metabonomic evaluation of livers from rats chronically treated with tamoxifen, mestranol, and phenobarbital. Metabonomics 1:87-94.
78. Schnackenberg, L. K., Dragan, Y. P., Reily, M. D., Robertson, D. G., and Beger, R. D. 2007. Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants. Metabolomics 2:87-100.
79. Schnackenberg, L. K., Jones, R. C., Thyparambil, S., Taylor, J. T., Han, T., Tong, W., Hansen, D. K., Fuscoe, J. C., Edmondson, R. D., Beger, R. D., and Dragan, Y. P. 2006. An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. OMICS 10:1-14.
80. Sener, G., Sehirli, A. O., Altunbas, H. Z., Ersoy, Y., Paskaloglu, K., Arbak, S., and Ayanoglu-Dulger, G. 2002. Melatonin protects against gentamicin-induced nephrotoxicity in rats. J. Pineal Res. 32:231-236.
81. Serkova, N. J., and Christians, U. 2005. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood. Ther. Drug Monit. 27:733-737.
82. Sherman, K. E. 1991. Alanine aminotransferase in clinical practice. A review. Arch. Intern. Med. 151:260-265.
83. Slim, R. M., Robertson, D. G., Albassam, M., Reily, M. D., Robosky, L., and Dethloff, L. A. 2002. Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats. Toxicol. Appl. Pharmacol. 183:108-116.
84. Soga, T., Baran, R., Suematsu, M., Ueno, Y., Ikeda, S., Sakurakawa, T., Kakazu, Y., Ishikawa, T., Robert, M., Nishioka, T., and Tomita, M. 2006. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 281:16768-16776.
85. Tilson, H. A., and Moser, V. C. 1992. Comparison of screening approaches. Neurotoxicology 13:1-13.
86. Vaidya, V. S., and Bonventre, J. V. 2006. Mechanistic biomarkers for cytotoxic acute kidney injury. Expert Opin. Drug Metab. Toxicol. 2:697-713.
87. Waner, T., and Nyska, A. 1991. The toxicological significance of decreased activities of blood alanine and aspartate aminotransferase. Vet. Res. Commun. 15:73-78.
88. Waters, N. J., Holmes, E., Williams, A., Waterfield, C. J., Farrant, R. D., and Nicholson, J. K. 2001. NMR and pattern recognition studies on the time-related metabolic effects of a-naphthylisothiocyante on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol. 14:1401-1412.
89. Waters, N. J., Waterfield, C. J., Farrant, R. D., Holmes, E., and Nicholson, J. K. 2006. Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J. Proteome Res. 5:1448-1459.
90. Williams, R. E., Jacobsen, M., and Lock, E. A. 2003. 1 H NMR pattern recognition and 31P NMR studies with D-serine in rat urine and kidney, time- and dose-related metabolic effects. Chem. Res. Toxicol. 16:1207-1216.
91. Williams, R. E., Lenz, E. M., Evans, J. A., Wilson, I. D., Granger, J. H., Plumb, R. S., and Stumpf, C. L. 2005a. A combined 1 H NMR and HPLC-MC-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. J. Pharm. Biomed. Anal. 38:465-471.
92. Williams, R. E., Lenz, E. M., Lowden, J. S., Rantalainen, M., and Wilson, I. 2005b. The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1 H NMR and HPLC-TOF MS. Mol. Biosyst. 1:166-175.
93. Williams, R. E., Lenz, E. M., Rantalainen, M., and Wilson, I. D. 2006. The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats. Mol. Biosyst. 2:193-202.
94. Wilson, I. D., Nicholson, J. K., Castro-Perez, J., Granger, J. H., Johnson, K. A., Smith, B. W., and Plumb, R. S. 2005. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4:591-598.
95. Yamada, R., Wakabayashi, Y., and Iwashima, A. 1984a. "In vivo" inhibition of murine liver aspartate aminotransferase by isoniazid. Acta Vitaminol. Enzymol. 6:29-39.
96. Yamada, R. H., Wakabayashi, Y., and Iwashima, A. 1984b. Inhibition of serum aspartate aminotransferase induced by isoniazid administration in mice. Acta Vitaminol. Enzymol. 6:289-293.
97. Yang, J., Xu, G., Zheng, Y., Kong, H., Wang, C., Zhao, X., and Pang, T. 2005. Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A214-221.
98. Yap, I. K., Clayton, T. A., Tang, H., Everett, J. R., Hanton, G., Provost, J. P., Charuel, C., Lindon, J. C., and Nicholson, J. K. 2006. An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J. Proteome Res. 5:2675-2684.
99. Yokoyama, T., Banta, S., Berthiaume, F., Nagrath, D., Tompkins, R. G., and Yarmush, M. L. 2005. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metab. Eng. 7:88-103.
100. Zeisel, S. H., Franklin, P. D., Alexander, E. A., Lamont, J. T., Sheard, N. F., and Beiser, A. 1991. Choline, an essential nutrient for humans. FASEB J 5:2093-2098.
101. Zhang, J., Herman, E. H., Robertson, D. G., Reily, M. D., Knapton, A., Ratajczak, H. V., Rifal, N., Honchel, R., Blanchard, K. T., Stoll, R. E., and Sistare, F. D. 2006. Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK & F 95654 in the spontaneously hypertensive rat. Toxicol. Pathol. 34:1-12.